N-(1-((2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide

Catalog No. :
ACIREF415
CAS No. :
182495-81-4
Molecular Formula :
C17H18FN3O5
Molecular Weight :
363.35

IUPAC Name:2'-Deoxy-2'-fluoro-N4-benzoyl-5-methylcytidine

N-(1-((2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(1-((2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide
IUPAC Name2'-Deoxy-2'-fluoro-N4-benzoyl-5-methylcytidine
Molecular FormulaC17H18FN3O5
Molecular Weight363.35
SMILESO=C(NC(C(C)=CN1[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2F)=NC1=O)C3=CC=CC=C3
InChI KeyMQFJFDMISFYWRE-BRXULGCHSA-N
Synonym2'-Deoxy-2'-fluoro-N4-benzoyl-5-methylcytidine;Cytidine, N-benzoyl-2'-deoxy-2'-fluoro-5-methyl- (9CI);N-benzoyl-2'-deoxy-2'-fluoro-5-methylCytidine;N4-benzoyl-5-methyl-2'-deoxy-2'-(R)-fluoro-cytidine
CAS No.182495-81-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACIREF415 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIREF415 route product structure diagram
    ACIREF415182495-81-4
Inquiry

2. ACIREF415 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIREF415 route product structure diagram
    ACIREF415182495-81-4
Inquiry

Comments (0)